March 11, 2008
Taking the breast cancer pill Femara can significantly reduce the chances that a woman's cancer will return, even long after she has stopped taking the estrogen blocker tamoxifen, researchers said in Chicago. They said post-menopausal women who took Femara from one to seven years after finishing a five-year regimen of tamoxifen reduced by 63% the risk the cancer would come back. The study results were published in the Journal of Clinical Oncology.
July 6, 2010 |
Anyone who has undergone a biopsy or other test to detect cancer knows the agony of waiting for the test results. Doctors face the dilemma of how to divulge the bad news to their patients. Call the minute you receive the results and let the patient know? Schedule a face-to-face office visit and explain the findings there? A new study suggests that doctors should usually disclose a cancer diagnosis in a personal setting, taking plenty of time to discuss what the diagnosis means and explain treatment options.
May 17, 2008 |
A growing number of women with early-stage breast cancer seem to be choosing to have the whole breast removed instead of just the cancerous lump, a Mayo Clinic study of about 5,500 women found. Mastectomies were standard treatment until 1990, when studies showed that women whose cancers were small and confined to the breast did just as well if they had less radical surgery followed by radiation. Researchers are not sure what is responsible for the new trend, but speculate that newer tests like MRI scans are finding more cancers, or flagging so many suspicious spots that women want the breast removed for peace of mind.
June 2, 2008
Childhood cancer: In a May 26 article on survivors of childhood cancer, Dr. Jacqueline Casillas was referred to as director of the UCLA-Livestrong Survivorship Center of Excellence. She is associate director; the director is Dr. Patricia Ganz. The article said the UCLA-Livestrong center was in the Mattel Children's Hospital. It is part of UCLA's Jonsson Comprehensive Cancer Center. The same article said that a study of childhood cancer survivors that found a five to 10 times greater risk of heart disease in early adulthood (compared with healthy siblings)
June 2, 2008 |
A simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said. The two-year survival rate averages only about 15%, mainly because the disease, which kills 1.3 million people globally a year, is often diagnosed in advanced stages. Preliminary findings of a study presented in Chicago at the annual meeting of the American Society of Clinical Oncology suggest that a specific genetic profile for lung cancer is present in the blood and can be detected with 88% accuracy.
February 7, 2011 |
Breast cancer survival rates have improved in recent years, and women have more treatment choices, including -- in cases of early-stage cancer -- the opportunity to forgo chemotherapy. A new study shows, however, that women who undergo chemotherapy experience more symptoms in the year after surgery. Researchers led by Dr. Patricia A. Ganz of UCLA, found that women who have chemotherapy can have symptoms that persist for even a year. These include vaginal symptoms, musculoskeletal pain and weight problems.